MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202517042642 A) filed by Tubulis Gmbh, Planegg, Germany, on May 2, for 'novel antibody drug conjugates with novel napi2b antibodies, therapeutic methods and uses thereof.'
Inventor(s) include Helma-Smets, Jonas; Vogl, Annette; Schmitt, Saskia; Mai, Isabelle; Herterich, Sarah; Schumacher, Dominik; Kasper, Marc-Andre; Cyprys, Philipp; and Gerlach, Marcus.
The application for the patent was published on July 25, under issue no. 30/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to novel anti-NaPi2b antibodies, novel antibody-drug-conjugates (ADCs) based thereon as well as to therapeutic method...